nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Skin candida—Riluzole—amyotrophic lateral sclerosis	0.111	0.133	CcSEcCtD
Linezolid—Biliary colic—Riluzole—amyotrophic lateral sclerosis	0.0525	0.0627	CcSEcCtD
Linezolid—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.0307	0.0366	CcSEcCtD
Linezolid—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0265	0.0317	CcSEcCtD
Linezolid—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0312	CcSEcCtD
Linezolid—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.0254	0.0303	CcSEcCtD
Linezolid—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0244	0.0291	CcSEcCtD
Linezolid—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.0234	0.028	CcSEcCtD
Linezolid—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0215	0.0257	CcSEcCtD
Linezolid—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0215	0.0257	CcSEcCtD
Linezolid—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0202	0.0241	CcSEcCtD
Linezolid—MAOB—nerve—amyotrophic lateral sclerosis	0.0193	0.134	CbGeAlD
Linezolid—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0186	0.0222	CcSEcCtD
Linezolid—MAOA—nerve—amyotrophic lateral sclerosis	0.0165	0.114	CbGeAlD
Linezolid—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0197	CcSEcCtD
Linezolid—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0151	0.018	CcSEcCtD
Linezolid—MAOB—hindbrain—amyotrophic lateral sclerosis	0.0145	0.1	CbGeAlD
Linezolid—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0166	CcSEcCtD
Linezolid—MAOA—hindbrain—amyotrophic lateral sclerosis	0.0124	0.0854	CbGeAlD
Linezolid—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0146	CcSEcCtD
Linezolid—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0145	CcSEcCtD
Linezolid—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0138	CcSEcCtD
Linezolid—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0133	CcSEcCtD
Linezolid—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0129	CcSEcCtD
Linezolid—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0122	CcSEcCtD
Linezolid—Injury—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0121	CcSEcCtD
Linezolid—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00977	0.0117	CcSEcCtD
Linezolid—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00933	0.0111	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0093	0.0111	CcSEcCtD
Linezolid—MAOB—embryo—amyotrophic lateral sclerosis	0.00905	0.0626	CbGeAlD
Linezolid—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00858	0.0103	CcSEcCtD
Linezolid—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00846	0.0101	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00837	0.01	CcSEcCtD
Linezolid—MAOB—brainstem—amyotrophic lateral sclerosis	0.0083	0.0574	CbGeAlD
Linezolid—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00823	0.00983	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0082	0.00979	CcSEcCtD
Linezolid—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00788	0.00941	CcSEcCtD
Linezolid—MAOA—embryo—amyotrophic lateral sclerosis	0.00773	0.0534	CbGeAlD
Linezolid—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00763	0.00912	CcSEcCtD
Linezolid—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00751	0.00898	CcSEcCtD
Linezolid—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00721	0.00861	CcSEcCtD
Linezolid—MAOA—brainstem—amyotrophic lateral sclerosis	0.00708	0.0489	CbGeAlD
Linezolid—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00702	0.00839	CcSEcCtD
Linezolid—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00698	0.00834	CcSEcCtD
Linezolid—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00646	0.00772	CcSEcCtD
Linezolid—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00643	0.00768	CcSEcCtD
Linezolid—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00764	CcSEcCtD
Linezolid—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00638	0.00762	CcSEcCtD
Linezolid—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00726	CcSEcCtD
Linezolid—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.00579	0.04	CbGeAlD
Linezolid—Chills—Riluzole—amyotrophic lateral sclerosis	0.00577	0.00689	CcSEcCtD
Linezolid—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00659	CcSEcCtD
Linezolid—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00655	CcSEcCtD
Linezolid—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00643	CcSEcCtD
Linezolid—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00517	0.00618	CcSEcCtD
Linezolid—MAOB—spinal cord—amyotrophic lateral sclerosis	0.00516	0.0357	CbGeAlD
Linezolid—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00611	CcSEcCtD
Linezolid—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00601	CcSEcCtD
Linezolid—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00599	CcSEcCtD
Linezolid—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.00494	0.0341	CbGeAlD
Linezolid—Cough—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00584	CcSEcCtD
Linezolid—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00485	0.00579	CcSEcCtD
Linezolid—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00577	CcSEcCtD
Linezolid—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00557	CcSEcCtD
Linezolid—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00546	CcSEcCtD
Linezolid—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00534	CcSEcCtD
Linezolid—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00444	0.0053	CcSEcCtD
Linezolid—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00528	CcSEcCtD
Linezolid—MAOA—spinal cord—amyotrophic lateral sclerosis	0.0044	0.0304	CbGeAlD
Linezolid—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00436	0.0052	CcSEcCtD
Linezolid—MAOB—nervous system—amyotrophic lateral sclerosis	0.00435	0.0301	CbGeAlD
Linezolid—MAOB—central nervous system—amyotrophic lateral sclerosis	0.00419	0.0289	CbGeAlD
Linezolid—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00494	CcSEcCtD
Linezolid—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0049	CcSEcCtD
Linezolid—MAOB—cerebellum—amyotrophic lateral sclerosis	0.00409	0.0283	CbGeAlD
Linezolid—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00487	CcSEcCtD
Linezolid—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00485	CcSEcCtD
Linezolid—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0048	CcSEcCtD
Linezolid—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00474	CcSEcCtD
Linezolid—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00471	CcSEcCtD
Linezolid—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00471	CcSEcCtD
Linezolid—Pain—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00467	CcSEcCtD
Linezolid—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00467	CcSEcCtD
Linezolid—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00446	CcSEcCtD
Linezolid—MAOA—nervous system—amyotrophic lateral sclerosis	0.00371	0.0256	CbGeAlD
Linezolid—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00434	CcSEcCtD
Linezolid—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00431	CcSEcCtD
Linezolid—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00431	CcSEcCtD
Linezolid—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00357	0.0247	CbGeAlD
Linezolid—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00349	0.0241	CbGeAlD
Linezolid—MAOB—brain—amyotrophic lateral sclerosis	0.00332	0.023	CbGeAlD
Linezolid—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00392	CcSEcCtD
Linezolid—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00386	CcSEcCtD
Linezolid—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00373	CcSEcCtD
Linezolid—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00361	CcSEcCtD
Linezolid—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00347	CcSEcCtD
Linezolid—Rash—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00344	CcSEcCtD
Linezolid—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00344	CcSEcCtD
Linezolid—Headache—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00342	CcSEcCtD
Linezolid—MAOA—brain—amyotrophic lateral sclerosis	0.00284	0.0196	CbGeAlD
Linezolid—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00324	CcSEcCtD
Linezolid—MAOA—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.00192	0.105	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00189	0.104	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00176	0.0965	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—GSR—amyotrophic lateral sclerosis	0.00134	0.0737	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00119	0.065	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.000842	0.0462	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.000751	0.0412	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	0.000607	0.0333	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00046	0.0253	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000458	0.0251	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000319	0.0175	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000295	0.0162	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000295	0.0162	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000295	0.0162	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000294	0.0161	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000284	0.0156	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00026	0.0143	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000244	0.0134	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000242	0.0133	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000242	0.0133	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000234	0.0128	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000226	0.0124	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000218	0.0119	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000215	0.0118	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000199	0.0109	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000185	0.0102	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000185	0.0102	CbGpPWpGaD
Linezolid—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000179	0.00982	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000179	0.00982	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000165	0.00906	CbGpPWpGaD
Linezolid—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000164	0.00898	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000153	0.00837	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000152	0.00835	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000147	0.00804	CbGpPWpGaD
Linezolid—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000143	0.00785	CbGpPWpGaD
Linezolid—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000129	0.0071	CbGpPWpGaD
Linezolid—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000112	0.00616	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000112	0.00616	CbGpPWpGaD
Linezolid—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000103	0.00564	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	9.81e-05	0.00538	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.55e-05	0.00524	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	9.05e-05	0.00497	CbGpPWpGaD
Linezolid—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	8.98e-05	0.00493	CbGpPWpGaD
Linezolid—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	8.12e-05	0.00445	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	7.62e-05	0.00418	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	7.43e-05	0.00408	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	6.47e-05	0.00355	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	6.15e-05	0.00338	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	5.68e-05	0.00312	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	4.66e-05	0.00256	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.99e-05	0.00219	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.67e-05	0.00201	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	3.02e-05	0.00166	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.51e-05	0.00138	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.3e-05	0.00126	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.07e-05	0.00114	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	1.9e-05	0.00104	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.3e-05	0.000712	CbGpPWpGaD
